Skip to main content

German Survey Finds 80% Would Rather Open A Specialty Cannabis Store

Earlier this year, on April 1, 2024, Germany adopted the historic CanG law that legalized cannabis possession, cultivation, and use by adults. Germany may have not been the first country in Europe to do so, but legalization in Germany is undeniably the most significant cannabis policy modernization victory in Europe’s history.

Due to European Union agreements, legalization in Germany differs in many aspects compared to legalization in the Western Hemisphere. Whereas adult-use cannabis products can be sold nationwide in Uruguay and Canada at retail outlets, legalization in Europe focuses more on boosting public health outcomes and research.

Starting on July 1, 2024, people could start applying to launch German adult-use cannabis cultivation associations. The associations are member-based and are one of the main ways that cannabis can be legally obtained by adults in Germany.

The German Cannabis Business Association (BvCW) recently conducted a poll of its members asking if people in Germany would rather open a cannabis cultivation association or a specialty cannabis store.

“In our non-representative survey, which we shared in our newsletter, we asked from 07.10.2024 – 15.10.2024: “If you had the choice, would you rather set up a cultivation association or open a specialty store or licensed point of sale for cannabis as part of a model project?” BvCW stated in a recent newsletter.

“The respondents voted as follows: 50% definitely wanted a specialist shop/licensed point of sale, 30% rather wanted a specialist shop/licensed point of sale, 10% rather wanted a growers’ association, 5% definitely wanted a growers’ association and 5% partly/partly.” BvCW stated about the results of the survey.

“Thus, over 80% said they rather or definitely wanted to open a specialist shop/licensed point of sale.” BvCW also stated.

In addition to home cultivation and cannabis cultivation associations, Germany’s legalization model will eventually also incorporate regional adult-use cannabis commerce pilot trials, similar to what is already in place in the Netherlands and Switzerland but on a much larger scale.

Unfortunately, until European Union agreements are modernized, nationwide sales at retail outlets like what is in place in Uruguay and Canada will have to wait. With that being said, Germany will continue to lead the charge to achieve such policy modernization at the continental level, and a more robust commerce system will no doubt be permitted in Germany in the future.

The Global Cannabis Community Loses A Legend

The International Cannabis Business Conference team posts this article with a heavy heart. The global cannabis community lost a giant this month with the passing of Jürgen Neumeyer. Mr. Neumeyer has been a part of the International Cannabis Business Conference family for many years, and he will be dearly missed by everyone who was blessed to know him.

Below is a message sent out by the German Cannabis Business Association (BvCW) commemorating the life and accomplishments of Jürgen Neumeyer. He was truly a legend:

Our co-founder and managing director Jürgen Neumeyer died unexpectedly on Wednesday, October 9, 2024, during a family visit to his hometown. At the age of 56, he left behind a comprehensive life’s work. He was able to realize his greatest political goal in life, the decriminalization of cannabis, during his lifetime.

For decades, Jürgen had dedicated a large part of his life to the vision that cannabis users in Germany would no longer be criminalized. In various roles in politics and business, he did not lose sight of this goal and was able to celebrate an important milestone on April 1, 2024. The cannabis law would look different today without Jürgen’s tireless work. But not all of his goals have been achieved yet – be it improvements in the area of ​​industrial hemp or the creation of a legal market for recreational cannabis.

His drug policy career began in the 1990s with the Federal Association of Jusos, followed by a career as an employee for various members of the German Bundestag, publicist and networker. As the founding managing director of the “ Netzwerk Berlin” he was committed to the legalization of cannabis, among other things, and published several books on the subject. In addition to his editorial work for the magazine “ Berliner Republik”, he was also active in its management. He was also a co-founder of the think tank “ Das Progressive Zentrum eV”, as well as the non-partisan association “ Walkkreis eV”, which was firmly anchored in the Berlin government district with a political pub of the same name. His passion for cannabis policy led him to head political communications for the German Hemp Association (DHV) for several years. Jürgen recognized early on that an independent interest group was needed. He was the driving force behind the founding of an association for the German cannabis industry and was managing director of the industry association Cannabiswirtschaft e.V. from 2019 until his death. V. (BvCW) and CS Cannabis Service GmbH.

Our association, which represents all sectors of the industry (industrial hemp, medicinal cannabis & stimulants as well as technology, trade & services), grew to over 100 members within 5 years under his management, published over 40 specialist publications, many statements and press releases, and organized parliamentary meetings and specialist events. As a trade association representing all specialist areas of the cannabis industry, we became the largest of its kind in Europe. With all our commitment, we made significant contributions to the creation of the Cannabis Act, the abolition of the Narcotics Act status and the urgently awaited abolition of the intoxication clause with the Industrial Hemp Liberalization Act.

Jürgen Neumeyer had set himself and the association many other tasks, such as setting up the cannabis industry directory and the cannabis specialist publishing house, which are still in their infancy, a cannabis roadshow and the long-term goal of a “House of the Cannabis Industry” in Berlin. The focus was always on the current political goals, such as the model projects for cannabis (“Pillar 2”), but also many other construction projects such as hemp as a building material and the promotion of renewable raw materials.

With his death, we have not only lost a talented manager, friend and networker, but also an empathetic and authentic fellow human being who knew how to lighten up any professional and private conversation with his cheerful nature. He was also notorious for his extensive knowledge of winemaking and beer brewing, as well as his passion as a DJ. He was greatly respected and valued by everyone for his unique style.

Global Cannabis Testing Market Projected To Reach $5.87 Billion By 2031

The emerging global cannabis industry is comprised of various sectors, with some having more profit potential than others. One sector of the worldwide cannabis industry that shows the most promise is the cannabis product testing sector.

Every legal cannabis market on the planet has different policies and regulations to some degree, but one constant seems to be that cannabis products must be tested before hitting retail shelves, and rightfully so. Cannabis testing ensures that products are safe for human consumption.

Additionally, cannabis testing captures cannabinoid levels which is a requirement in most legal cannabis markets. It lets regulators know if cannabis products fit within certain THC/CBD parameters and helps inform consumers and patients of the cannabinoid content of the products that they are purchasing.

In addition to cannabinoid levels, testing can also determine terpene profiles, which is an emerging area of cannabis testing and research.

According to a recent market analysis by Coherent Market Insights, the global cannabis testing services market is estimated to be valued at $2.38 billion in 2024 and is projected to reach $5.87 billion in value by 2031.

“The Cannabis Testing Services market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements.” the market analysts stated.

A separate market analysis recently published by SkyQuest Technology Consulting projects an even larger rate of growth for the global cannabis testing market, projecting that the sector will reach a value of $21.9 Billion by 2031, with a CAGR of 13.5% during the forecast period (2024-2031).

“The use of cannabis in the treatment of several neurological and psychiatric conditions has also increased dramatically along with the increasing prevalence and production of marijuana. This growing trend is expected to drive significant growth in the cannabis testing market during the forecast period.” Skyquest stated about its analysis.

“Asia-Pacific within the cannabis testing market will witness an outstanding CAGR of 25.9%, indicating a vast upward trend.” the analysts also stated.

Jersey Campaign Highlights How Cannabis Has Gone Mainstream In Germany

One area of society that cuts across political lines and socioeconomic backgrounds is sports. People from all walks of life love sports, with football (soccer) being the most popular sport around the world. Football is especially popular in Europe where hundreds of millions of fans are located.

With that in mind, it was a very big deal when the “Endlich” special jersey campaign was recently launched by SC Paderborn 07, Four 20 Pharma, and the Sanity Group, with part of the campaign involving pro-cannabis messaging being prominently placed at a recent football match.

Sport-Club Paderborn 07 e.V., commonly known as SC Paderborn 07 or SC Paderborn, is a German association football club based in Paderborn, North Rhine-Westphalia.

“Whether it’s the 2nd Bundesliga, Bundesliga or international football: special jerseys have become established and are often a real collector’s item for fans of the respective teams. They are usually issued for a special occasion such as a Champions League game. But sometimes they also have a much more serious background – as with the “Endlich” special jersey campaign by SC Paderborn 07, Four 20 Pharma GmbH (Four 20 Pharma) and the Sanity Group.” Four 20 Pharma GmbH stated about the effort.

“The jersey, which is all green with white accents and in which the SC Paderborn 07 team played against Jahn Regensburg, aims to draw attention to the issue of medicinal cannabis and counteract possible stigmatization and prejudice. There were also a variety of activities in and around the stadium – for example information stands and flyers on the seats.” the company also stated.

Below is footage from the match:

“The SCP07 team came onto the pitch dressed entirely in green and with a striking “Endlich” lettering and presented the jersey to the fans. During halftime, the special jerseys were then distributed using a “jersey cannon”. The oversized, inflatable jersey in the “Endlich” design on the forecourt was also an eye-catcher and a popular photo motif.” Four 20 Pharma GmbH stated.

“The other offers from the Endlich initiative were more informative – for example, the interior interview before the game or the 15,000 flyers that were distributed throughout the stadium and conveyed facts about the topic of medicinal cannabis and drew attention to a special Endlich Instagram filter. At information stands, visitors could also talk to medicinal cannabis experts, learn important facts and clarify questions.” they also stated.

Such a powerful message in such a mainstream setting is a big deal by every measure. Putting pro-cannabis messaging on such a grand stage no doubt reached parts of society that other pro-cannabis efforts simply cannot reach. It is an unparalleled effort that will reduce the stigma surrounding cannabis in Germany and beyond.

“After all, this is how we get into conversation with people who have not yet dealt with the topic or have not dealt with it sufficiently, or who are generally opposed to it. And that is exactly where we want to start: initiate a factual discussion, take the topic out of the dirty corner.” says Finn Hänsel, Managing Director & Founder of the Sanity Group.

“The feedback was overall positive, similar to the presentation of Four 20 Pharma as the main and jersey sponsor. We were happy to support this and with the joint special jersey campaign we helped to bring it even more into the public eye and to remove the taboo.” said Martin Hornberger, SCP 07 managing director.

The effort was also supported by TV presenter Matthias Killing (Sat.1 breakfast television), influencer Max Büchsenschütz, and professional athlete and motocross rider Tristan Hanak, who all participated in the campaign.

CBD Skincare Market Expected To Experience Tremendous Growth

The overall cannabidiol (CBD) industry has experienced significant growth in recent years due to regulatory reforms and increased demand by consumers and patients. One sector that is witnessing the most growth is the CBD skincare market, which is projected to expand considerably in the coming years.

According to a recent market analysis by Allied Market Research, the global CBD skincare market is projected to reach $8.9 billion in value by 2033, a CAGR of 19.5%. The same market analysis estimates that the CBD skincare market was valued at $1.5 billion in 2023.

“Continuous innovation and new product launches by major skincare brands are attracting consumers and expanding the market. The influence of social media and celebrity endorsements is further enhancing market growth.” the researchers stated.

“Moreover, the increased availability of CBD skincare products through various retail channels, including online stores, specialty beauty shops, and health stores, is facilitating market expansion.” the researchers also stated.

A separate recent market analysis by SNS Insider also projects that the CBD skincare market will experience tremendous growth in the near future. According to SNS Insider, the CBD skincare market will be worth a projected $22.19 billion by 2032, a CAGR of 28.7%.

“Industry reports suggest that CBD skincare products are going to move upward, as growing awareness regarding the anti-inflammatory and antioxidant effects of CBD is entering as one of the largest most sought-after ingredients in modern skincare routines.” SNS Insider stated about the CBD skincare market. The market researchers also determined the following:

  • In 2023, the oils segment accounted for over 38.8 % of the total market share in the CBD skincare market
  • The segment of department stores had the highest share, above 29.0% in 2023
  • Hemp-based products topped the market with over 63.5% share in the year 2023
  • North America was established as a market leader in the CBD skincare product market in 2023

Additionally, according to a recent analysis by Research and Markets, the CBD nutraceuticals market will be worth an estimated $29.1 billion by 2030. The market analysis estimates that the CBD nutraceuticals market will be worth $9.7 billion in 2024.

CBD Nutraceuticals Market Projected To Be Worth $29.1 Billion By 2030

The emerging cannabidiol (CBD) nutraceuticals sector is expected to experience tremendous growth through the remainder of this decade, with a recent report by Research and Markets projecting that the CBD nutraceuticals market alone will be worth an estimated $29.1 billion by 2030. The market analysis estimates that the CBD nutraceuticals market is worth $9.7 billion in 2024.

“Worldwide, the market for CBD Nutraceuticals is poised to record an above-average growth over the analysis period, the crucial reasons for which are the increase in demand for plant-based foods, growing awareness concerning benefits of CBD nutraceuticals, innovative products in the pipeline and CBD nutraceuticals in capsule & softgel forms undergoing further advancements.” the researchers stated in their analysis.

“North America represents the primary global market for CBD Nutraceuticals, the reasons for which include introduction of the 2018 Farm Bill that legalized hemp cultivation and processing of hemp-derived products, demand from consumers after getting to know the benefits of CBD-based Nutraceuticals, major companies active in the region and a significant rise in geriatric population.” Research and Markets stated.

“Asia-Pacific, though, is anticipated to be the fastest growing global region for CBD Nutraceuticals, factors for which comprise entry of leading global players, an increase in lifestyle-associated diseases & other health disorders and greater knowledge pertaining to healthier eating routines.” the market researchers also stated.

“CBD Oils account for the largest share, as they have great versatility in being used in a range of applications, such as capsules, tinctures and cosmetics. However, the global demand for CBD Isolates is likely to maintain the fastest growth, since these are considered to offer high purity, making them ideal as CBD formulations in products that need exact concentrations of CBD.” the researchers stated about subsectors of the market.

“A high demand has been evident for CBD Tinctures, since they widely utilized in treating insomnia, cancer cell growth, seizures, anxiety, depression and chronic pain, as well as hyperglycemia, muscle spasms, psychosis and bone degeneration. However, the demand for CBD Capsules & Softgels is expected to exhibit the fastest growth over the analysis period, since they are more convenient to consume and are also travel-friendly.” the researchers concluded.

A previous market analysis conducted by Market Research Future estimated that the global CBD industry was worth $18.43 billion in 2023 and that the market would reach a projected $59.43 billion by 2030.

UK Cannabis Legalization Could Generate £9.5 Billion Per Year

Legalizing cannabis for adult use in the United Kingdom and taxing and regulating sales could generate as much as £9.5 billion per year according to a new analysis published by CLEAR. CLEAR is a cannabis reform advocacy organization based in the UK.

“Overall the net benefit to the taxpayer of a taxed and regulated cannabis market could range from £3.4 Billion to £9.5 Billion per annum, with a best estimate of £6.7 Billion per year at recent market levels.” the organization stated.

The market projection is part of a recently published analysis by CLEAR titled, ‘How to Regulate Cannabis in Britain.’ The recently published analysis is the third version of the organization’s plan, with the first version being published on September 12th, 2011, and the second version being published on October 18th, 2013.

“The plan is predicated on the fact that the prohibition of cannabis provides no control whatsoever over this multi-billion-pound market. Present policy is, in fact, an abdication of responsibility by government to organised crime.” CLEAR stated in its analysis.

CLEAR is proposing, among other things, the creation of an “inspectorate as an executive agency of government to include a head office, 10 analysis laboratories, 10 bonded warehouses, 10 regional offices, 100 local offices with a total of 2620 staff and an annual budget of around £200 million.”

“Wholesale distribution and retail licensing would be based on the tobacco/alcohol model. Licences would only be granted to a “fit and proper” person or company. Previous nonviolent cannabis convictions would not disqualify an applicant. There would be a duty of responsibility on retailers not to supply to someone obviously intoxicated on cannabis or any other substance. A limit of 10 grams per transaction could be considered although there is currently no limit on sales of alcohol which is a very much more dangerous drug. Sales would be to adults only and ID would be required if there was any doubt of the customer’s age.” CLEAR stated about its proposed regulated sales model.

In addition to legalized sales, CLEAR is also proposing the legalization of ‘cannabis cafes’ and ‘cannabis social clubs,’ as well as permitting adults to cultivate up to three plants ‘under artificial lighting’ and another three plants ‘under natural light.’

“Alternatively, without artificial lighting, a total of six plants under natural light. Also included would be a separate propagation area for cuttings and seedlings of up to one square metre.” CLEAR stated in its report.

BvCW Poll Finds 88% Support For Legal Cannabis Plant Sales In Germany

The German Cannabis Business Association (BvCW) recently conducted a poll asking the question “Should the commercial trade in cannabis cuttings be legal for people over 18, in addition to distribution by cultivation associations?” (translated from German to English).

According to the BvCW poll, which was conducted from September 16, 2024 – September 23, 2024, as part of the organization’s newsletter, 88% of respondents selected ‘yes’, 2% selected ‘partly’, 3% selected ‘rather no’, 5% selected ‘no’, and 2% selected ‘don’t know.’

Starting on April 1st, 2024, adults aged 18 or older can cultivate up to three plants in Germany in their private residences. In order for home cultivators to start their gardens, they first need to acquire cannabis genetics in the form of cannabis seeds or cuttings/clones.

Limiting home cultivators in Germany to only seeds makes no rational sense being that the seed will eventually turn into a small plant anyway. Cannabis cuttings/clones provide some unique advantages over seeds that many cultivators prefer, including speeding up the cultivation process. Prohibiting them serves no purpose other than to perpetuate the illogical policies of Germany’s past.

A recent YouGov poll in Germany found that 7% of poll participants indicated that they had already purchased cannabis seeds or cuttings/clones since legalization took effect. In addition to the 7% of poll participants indicating that they had already purchased cannabis genetics for their home gardens, another 11% of poll participants responded that they plan to purchase cannabis genetics in the future.

Home cannabis cultivation by adults for recreational purposes is also legal in Uruguay, Canada, Malta, Luxembourg, South Africa, and in many states in the U.S. Major court decisions in other nations also provide some level of protection for cultivating personal amounts of cannabis.

Global Cannabis Seeds Market Projected To Reach $6.5 Billion By 2031

The global cannabis seed market is projected to experience significant growth between now and 2031 according to a market report by Allied Market Research. The market researchers estimate that the value of the worldwide cannabis seed market was $1.3 billion in 2021 and that the sector’s value will increase to $6.5 billion by 2031 (a CAGR of 18.4%).

Increased demand for cannabis seeds is due to various factors, not the least of which is laws being modernized around the globe to permit the sales and purchases of cannabis seeds. A great example of that can be found in Germany where, as of April 1st, 2024, adults can cultivate up to three cannabis plants in their private residences.

Many German home cultivators are purchasing seeds to populate their home gardens. A recent YouGov poll in Germany found that 7% of poll participants indicated that they had already purchased cannabis seeds (or clones) since legalization took effect.

In addition to the 7% of poll participants indicating that they had already purchased cannabis genetics for their home gardens, another 11% of poll participants responded that they plan to purchase cannabis genetics in the future. Increased demand for cannabis seeds in Germany has resulted in booming sales among Europe’s seed banks.

Another part of the world where cannabis seeds are very popular is the United States. Currently, twenty-four states have adopted adult-use legalization laws in the U.S., as well as in Washington D.C. Not every jurisdiction permits home cultivation, however, most do, and many consumers are taking advantage of the recently afforded freedom.

In 2022, the DEA confirmed that cannabis seeds are legal now in the United States since they do not contain enough THC to be prohibited. Cannabis seeds are considered hemp under U.S. law, and hemp was legalized nationwide as part of the 2018 Farm Bill.

A great event dedicated to cannabis seeds is coming to San Francisco on December 7th-8th, 2024. More than 1,000 cannabis cultivators are expected to access the next generation of elite cannabis genetics at the first “Terpnami” seed fest in San Francisco. The event will feature over 20 cannabis seed breeders.

The public event is free to attend with RSVP and will be open from 11 a.m. to 4 p.m. Saturday, December 7th and Sunday, December 8th.

“Terpnami will feature fine food, drink, art, DJs, and festival attractions. A weekend of events including clone and seed drops at Bay Area dispensaries like 7 Stars, as well as VIP receptions wrap around the seed festival.” stated SFHashWeek in a recent blog post.

The event is organized by award-winning journalist and best-selling author David Downs. His ‘David Downs Presents’ production team brought more than 25 events to San Francisco in 2024, including the incredibly successful SF Weed Weeks and SF Hash Week.

“Everything in cannabis starts with great genetics and I’m honored to celebrate the breeders. Breeders are rockstars and deserve to be celebrated in a world-class city with a top-notch event. San Francisco in December is the perfect place for the cannabis genetics world to get together every year,” Downs said.

According to a recent survey conducted by The Harris Poll, most cannabis cultivators (61%) prefer to start their gardens with seeds. The study also found that:

  • 81% of cannabis consumers agree all Americans should have the right to grow at home
  • 62% of cannabis consumers would rather grow their own cannabis than buy it
  • 34% of cannabis consumers who have grown at home do so because they feel safer consuming their own home-grown flower compared to store-bought cannabis